Antipsychotics associated with weight gain, lower levels of good cholesterol in Alzheimer's patients

Share this article:
Two newer antipsychotic drugs have negative side effects in Alzheimer's patients. Both promote weight gain and one lowers levels of HDL "good" cholesterol, according to a new study.

The drugs associated with weight gain are olanzapine and quetiapine. Those who took olanzapine showed both weight gain and declines in HDL cholesterol. The study was to be published online April 15 in the American Journal of Psychiatry.

"These findings are especially troubling, because antipsychotics are associated with a higher risk of death and cerebrovascular adverse events in patients with dementia," according to principal investigator Dr. Lon S. Schneider in an American Psychiatric Association news release. "They're often used to minimize disruptive symptoms (such as psychosis or agitation), but patients should be monitored more closely."

Share this article:

More in News

Bill addressing admission status receives praise

A bill that would require hospitals to give patients a formal notice of their admission status has received strong support from healthcare associations.

Increased 'bed taxes' on nursing facilities warrant stricter federal oversight, report states

States have been increasingly taxing skilled nursing facilities and other healthcare providers to fund Medicaid in recent years, and federal authorities should look more closely at this trend, according to a government report released Tuesday.

Last chance: Tech Awards deadline arrives

Last chance: Tech Awards deadline arrives

There are hours left for innovative long-term care providers to enter the third annual McKnight's Excellence in Technology Awards. Submissions will be accepted until the stroke of midnight tonight.